文献速递临床试验与 GCP真实世界研究与卫生经济

克服入口障碍的康复桥接计划(BRIDGE):桥接门诊与常规照护对阿片类药物使用障碍患者随机对照试验的研究方案

Bridging Recovery Initiative Despite Gaps in Entry (BRIDGE): study protocol for a randomized controlled trial of a bridge clinic compared with usual care for patients with opioid use disorder.
PubMed 文献 · Trials · 2021-10-30

BRIDGE试验是一项单中心、实用性随机对照试验,纳入在成瘾会诊服务下启动阿片类药物使用障碍药物治疗(MOUD)的住院患者,随机转诊至联合定位的过渡性多学科桥接门诊或常规照护,分配概率由门诊容量决定。主要终点为住院时长,次要终点包括生活质量、照护衔接、丁丙诺啡或纳曲酮自报取药、已知复发性阿片使用率、再入院率和费用。

要点

  • BRIDGE试验比较桥接门诊与常规照护对住院阿片类药物使用障碍患者的效果。
  • 主要终点为住院时长,次要终点包括生活质量、照护衔接、再入院率和费用等。
  • 分配概率由桥接门诊容量决定,分析采用意向性治疗和完全协变量调整。

核心结论

  • 该正在进行中的实用性试验将为住院阿片类药物使用障碍患者主动衔接桥接门诊干预的有效性提供证据。

研究设计与样本

  • 单中心、实用性、随机对照临床试验,纳入在成瘾会诊服务下启动MOUD的住院阿片类药物使用障碍患者。
  • 患者被随机分配转诊至联合定位的过渡性多学科桥接门诊或常规照护,分配概率由门诊容量决定。
  • 主要分析采用意向性治疗(ITT)方法并进行完全协变量调整。

主要发现

  • 主要终点为住院时长。
  • 次要终点包括生活质量、照护衔接、自报丁丙诺啡或纳曲酮取药、已知复发性阿片使用率、再入院率和费用。
  • 实施终点包括转诊至桥接门诊的意愿、转诊者的就诊率以及患者不符合转诊条件的原因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with substance use disorders are overrepresented among general hospital inpatients, and their admissions are associated with longer lengths of stay and increased readmission rates. Amid the national opioid crisis, increased attention has been given to the integration of addiction with routine medical care in order to better engage such patients and minimize fragmentation of care. General hospital addiction consultation services and transitional, hospital-based "bridge" clinics have emerged as potential solutions. We designed the Bridging Recovery Initiative Despite Gaps in Entry (BRIDGE) trial to determine if these clinics are superior to usual care for these patients. METHODS: This single-center, pragmatic, randomized controlled clinical trial is enrolling hospitalized patients with opioid use disorder (OUD) who are initiating medication for OUD (MOUD) in consultation with the addiction consult service. Patients are randomized for referral to a co-located, transitional, multidisciplinary bridge clinic or to usual care, with the assignment probability being determined by clinic capacity. The primary endpoint is hospital length of stay. Secondary endpoints include quality of life, linkage to care, self-reported buprenorphine or naltrexone fills, rate of known recurrent opioid use, readmission rates, and costs. Implementation endpoints include willingness to be referred to the bridge clinic, attendance rates among those referred, and reasons why patients were not eligible for referral. The main analysis will use an intent-to-treat approach with full covariate adjustment. DISCUSSION: This ongoing pragmatic trial will provide evidence on the effectiveness of proactive linkage to a bridge clinic intervention for hospitalized patients with OUD initiating evidence-based pharmacotherapy in consultation with the addiction consult service. TRIAL REGISTRATION: ClinicalTrials.gov NCT04084392 . Registered on 10 September 2019. The study has been approved by the Vanderbilt Institutional Review Board. The current approved protocol is dated version May 12, 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Marcovitz DE, White KD, Sullivan W, et al. Bridging Recovery Initiative Despite Gaps in Entry (BRIDGE): study protocol for a randomized controlled trial of a bridge clinic compared with usual care for patients with opioid use disorder. Trials. 2021. PMID: 34717736. doi:10.1186/s13063-021-05698-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。